AP NEWS

United States Vaccines Market 2015-2018 & 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts - ResearchAndMarkets.com

November 26, 2018

DUBLIN--(BUSINESS WIRE)--Nov 26, 2018--The “United States Vaccines Market 2015 - 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts” report has been added to ResearchAndMarkets.com’s offering.

United States vaccines market is set to surpass US$ 21 Billion threshold by 2025

United States Vaccines Market 2015 - 2025: Top 21 Vaccines Analysis, Deal Trends, Players and Forecasts presents an in-depth assessment of the United States vaccines market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States vaccines market. The report includes historical data from 2015 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides clear insight into current and future developments of the United States vaccines market. The report also explores detailed analysis of top 21 vaccines market assessment in the United States from 2015 to 2017 and forecasts to 2025. The report also details the latest information about the vaccines pricing trends and regulatory landscape in the United States.

Additionally, the report includes an assessment of promising vaccines in the clinical development by major companies. Key trends in terms of collaboration, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the United States vaccines market.

The report concludes with the profiles of major players in the United States vaccines market. The key market players are evaluated on various parameters such as business overview, promising vaccines in clinical development and recent development.

The major companies dominating this market for its products, services, and continuous product developments are:

Pfizer Merck Sanofi Pasteur GlaxoSmithKline (GSK)

Top 21 Vaccines Covered Under This Report Are:

Prevnar/Prevnar 13 Gardasil/Gardasil 9 Fluzone Varivax Menactra Proquad Pneumovax FluLaval/Fluarix Havrix/Twinrix/Engerix-B MMR II Adacel Boostrix Bexsero Menveo Trumenba Shingrix Pentacel Recombivax HB Rotateq Rotarix Pediarix/Infanrix

The Latest Industry Data Included in this Report:

United States Vaccines Market Size & Analysis (2015 - 2025) The United States Vaccines Market Share & Y-o-Y Growth (%), 2015 - 2025 The United States Top 21 Vaccines Market Assessment & Opportunity (2015 - 2025) United States Vaccines Pricing Trends & Analysis United States Vaccines Regulatory System Major Deals in United States Vaccines Market Promising Vaccines in Clinical Development by Major Companies Key Market Drivers and Inhibitors of the United States Vaccines Market Major Companies Analysis

Key Topics Covered:

1. Executive Summary

2. United States Vaccines Market Size & Analysis (2015 - 2025)

3. United States Vaccines Market Share & Y-o-Y Growth (%), 2015 - 2025

4. Key Drivers and Inhibitors of the United States Vaccines Market

4.1 Market Drivers

4.2 Market Inhibitors

5. United States Top 21 Vaccines Market Assessment & Opportunity (Value), 2015 - 2025

5.1 Prevnar/Prevnar 13

5.2 Gardasil/Gardasil 9

5.3 Fluzone

5.4 Varivax

5.5 Menactra

5.6 Proquad

5.7 Pneumovax 23

5.8 Fluarix/FluLaval

5.9 Havrix/Twinrix/Engerix-B

5.10 M-M-R II

5.11 Adacel

5.12 Boostrix

5.13 Bexsero

5.14 Menveo

5.15 Trumenba

5.16 Shingrix

5.17 Pentacel

5.18 Recombivax HB

5.19 Rotateq

5.20 Rotarix

5.21 Pediarix/Infanrix

5.22 Other Vaccines

6. United States Vaccines Pricing Trends & Analysis

7. United States Vaccines Regulatory System

8. Major Deals in United States Vaccines Market

8.1 Merger & Acquisitions

8.2 Collaboration Deal

8.3 Licensing Agreement

8.4 Exclusive Agreement

8.5 Distribution Agreement

9. Key Companies Analysis

GlaxoSmithKline (GSK) Merck Pfizer Sanofi Pasteur

For more information about this report visit https://www.researchandmarkets.com/research/tktrh7/united_states?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181126005383/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Vaccines

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/26/2018 07:33 AM/DISC: 11/26/2018 07:33 AM

http://www.businesswire.com/news/home/20181126005383/en

AP RADIO
Update hourly